Japan-based Pentax Medical, a division of the Hoya Group specializing in endoscopic products, has announced plans to establish a new site in China focused on endoscope manufacturing, research and development (R&D), and the provision of related services. The facility will be located in Shanghai under the umbrella of Pentax Medical Shanghai Co., Ltd.
Expansion of Global R&D Network
The new R&D facility in Shanghai will be Pentax’s fourth, following the establishment of similar centers in Japan, the US, and Germany. These centers play a crucial role in allowing the company to interact directly with customers and integrate their feedback into the R&D process, ensuring that product development is aligned with market needs and customer expectations.
Enhancing Customer Interaction and Product Development
The addition of the Shanghai site to Pentax Medical’s global network of R&D facilities underscores the company’s commitment to innovation and customer-centric product development. By expanding its R&D capabilities to China, Pentax Medical aims to enhance its ability to respond to the specific needs of the Chinese market and contribute to the advancement of endoscopic technology worldwide.-Fineline Info & Tech
